EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 214 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 26 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,810,519 | $52,071,000 | 4.06% |
| Avoro Capital Advisors LLC | 330,635 | $9,509,000 | 3.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 766,424 | $22,043,000 | 1.32% |
| GREAT POINT PARTNERS LLC | 102,791 | $2,956,000 | 1.30% |
| Matarin Capital Management, LLC | 75,380 | $2,167,929,000 | 0.66% |
| GLOBEFLEX CAPITAL L P | 89,151 | $2,564,000 | 0.49% |
| LaSalle Street Capital Management, LLC | 15,897 | $457,000 | 0.45% |
| TFS CAPITAL LLC | 149,318 | $4,294,000 | 0.42% |
| TURNER INVESTMENTS LLC | 71,880 | $2,067,000 | 0.37% |
| NEW AMSTERDAM PARTNERS LLC/NY | 136,116 | $3,915,000 | 0.32% |